Home  /  Resource Library  /  Combination of fixed low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical Hodgkin lymphoma

Combination of fixed low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical Hodgkin lymphoma

Study investigated nivolumab combined with bendamustine for treatment of relapsed Hodgkin lymphoma in children.